- Home
- ADAG vs JEQ Comparison
ADAG vs JEQ Comparison
Compare ADAG & JEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- JEQ
- Stock Information
- Founded
- ADAG 2011
- JEQ 1990
- Country
- ADAG China
- JEQ United States
- Employees
- ADAG N/A
- JEQ N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- JEQ Air Freight/Delivery Services
- Sector
- ADAG Health Care
- JEQ Consumer Discretionary
- Exchange
- ADAG Nasdaq
- JEQ Nasdaq
- Market Cap
- ADAG 76.3M
- JEQ 88.1M
- IPO Year
- ADAG 2021
- JEQ N/A
- Fundamental
- Price
- ADAG $2.07
- JEQ $7.24
- Analyst Decision
- ADAG Strong Buy
- JEQ
- Analyst Count
- ADAG 1
- JEQ 0
- Target Price
- ADAG $8.00
- JEQ N/A
- AVG Volume (30 Days)
- ADAG 21.4K
- JEQ 32.0K
- Earning Date
- ADAG 07-24-2025
- JEQ 01-01-0001
- Dividend Yield
- ADAG N/A
- JEQ 7.05%
- EPS Growth
- ADAG N/A
- JEQ N/A
- EPS
- ADAG N/A
- JEQ N/A
- Revenue
- ADAG $103,204.00
- JEQ N/A
- Revenue This Year
- ADAG $6,488.89
- JEQ N/A
- Revenue Next Year
- ADAG $57.50
- JEQ N/A
- P/E Ratio
- ADAG N/A
- JEQ N/A
- Revenue Growth
- ADAG N/A
- JEQ N/A
- 52 Week Low
- ADAG $1.33
- JEQ $4.99
- 52 Week High
- ADAG $3.58
- JEQ $6.39
- Technical
- Relative Strength Index (RSI)
- ADAG 57.43
- JEQ 66.89
- Support Level
- ADAG $1.80
- JEQ $6.94
- Resistance Level
- ADAG $2.02
- JEQ $7.21
- Average True Range (ATR)
- ADAG 0.12
- JEQ 0.07
- MACD
- ADAG 0.02
- JEQ -0.00
- Stochastic Oscillator
- ADAG 67.31
- JEQ 87.88
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.